Canada’s KITS Eyecare sells eyewear online. It wants people to own multiple pairs of glasses, similar to how they have many scarves and headscarves. The advantage of the business is its special online vision test technology and its own production facilities, allowing it to keep prices low and quickly deliver glasses to customers. In July of this year, its share price rose above its IPO price for the first time since the company went public three years ago. The stock, having gained more than 60% since the beginning of the year, is now trading near the target price of analysts.

What KITS is doing to transform itself from an online glasses store into a major retailer

The first vaping addiction treatment, developed by Achieve Life Sciences, has been designated a "breakthrough therapy" by regulators, the company <a href="https://ir.achievelifesciences.com/news-events/press-releases/detail/204/achieve-life-sciences-announces-fda-grants-breakthrough">reported</a>. This status means the company <a href="https://ir.achievelifesciences.com/news-events/press-releases/detail/204/achieve-life-sciences-announces-fda-grants-breakthrough">can</a> get the product to market faster and skip the last phase of clinical trials. Achieve’s stock gained on the news.

Vaping addiction treatment by Achieve Life Sciences gets breakthrough designation

Quotes on shares of Envoy Medical, a developer of fully implanted hearing systems, <a href="https://www.nasdaq.com/market-activity/stocks/coch">jumped</a> 14.5% on Wednesday, July 31. Buoying the stock was news of a U.S. Senate <a href="https://www.govtrack.us/congress/bills/118/s4829">bill</a> that, if passed, would make the company's implants eligible for insurance coverage, the company <a href="https://www.morningstar.com/news/globe-newswire/9196388/bipartisan-senate-bill-seeks-to-clarify-that-implanted-active-middle-ear-hearing-devices-are-prosthetics-not-hearing-aids-making-them-eligible-for-medicare-coverage">reported</a>. According to Envoy Medical, nearly 40 million Americans suffer from disabling hearing loss.

Envoy stock jumps on news its hearing implants might become eligible for insurance coverage

In July, the Russell 2000 small-cap index has outpaced the tech-heavy Nasdaq Composite by 12.7 percentage points, according to Dow Jones Market Data <a href="https://www.wsj.com/livecoverage/stock-market-today-earnings-dow-sp500-nasdaq-live-07-30-2024/card/small-caps-widen-lead-over-nasdaq-UFBbDxVDkp4Yy3bVt3Xs">cited</a> by the . If this trend holds until the end of the trading day today, the last day of the month, it will mark the biggest monthly performance gap between the two indexes since February 2001.

Gap between Russell 2000 and Nasdaq Composite nears widest since 2001

Quotes on shares of CNS Pharmaceuticals, a developer of drugs to treat brain and central nervous system cancers, <a href="https://finance.yahoo.com/quote/CNSP/">plummeted</a> more than 60% on Tuesday, July 30. This came after an agreement was <a href="https://assets.cnspharma.com/production/filings/html/form-8-K-0001683168-24-005118.html?dm=1722407422">announced</a> with Cortice Biosciences that gives CNS Pharma the intellectual property rights to a brain cancer treatment molecule in four countries in exchange for shares and royalties from future sales.

Stock of brain cancer drug developer sinks 60% after deal announcement

has published a <a href="https://www.barrons.com/articles/best-small-cap-stocks-funds-fb970c89">Morningstar-compiled</a> list of the most popular stocks with small-cap funds. The past month <a href="https://kz.kursiv.media/2024-07-26/mrdr-jpmorgan/">has been great</a> for small-cap stocks, the publication notes, but navigating them can be quite challenging given the lack of media attention and Wall Street analyst coverage.  sought to find out what professional investors are buying.

Morningstar names 10 most popular stocks with small-cap funds

Shares of La Rosa Holdings, a provider of real estate brokerage and related services, <a href="https://www.nasdaq.com/market-activity/stocks/lrhc">plunged</a> almost 12% in trading on Monday, July 29. This came after the company <a href="https://s3.amazonaws.com/sec.irpass.cc/2686/0001013762-24-001822.htm">announced</a> that, with the consent of the majority shareholder, it had sold a promissory note worth around $0.5 million, along with shares and warrants, to an unnamed investor. Note that a previous attempt to raise capital had been called off following a negative reaction from investors. 

Real estate broker La Rosa Holdings sees stock plummet after issuing new shares

Quotes on shares of Above Food, a regenerative agriculture company, plummeted following a corporate <a href="https://abovefood.com/wp-content/uploads/2024/07/Above-Food-Announces-Business-Update_Final.pdf">update</a> for investors. The company <a href="https://abovefood.com/wp-content/uploads/2024/07/Above-Food-Announces-Business-Update_Final.pdf">acknowledged</a> that it  lacked working capital for growing its business in the 2024 fiscal year (ended January 31, 2024). As a result, revenue for the full year was lower than 2023, while its gross loss increased nearly fivefold.

Regenerative agriculture company Above Food’s update fails to impress investors

Quotes on shares of ProMIS Neurosciences, a developer of drugs for Alzheimer's disease and amyotrophic lateral sclerosis (ALS), <a href="https://www.nasdaq.com/market-activity/stocks/pmn">dropped</a> more than 20% on Friday, July 26. The company announced a <a href="https://www.promisneurosciences.com/investors/news-events/press-releases/detail/224/promis-neurosciences-announces-up-to-122-7-million-private">private placement</a> for up to $122.7 million, along with <a href="https://www.promisneurosciences.com/investors/news-events/press-releases/detail/225/promis-neurosciences-reports-positive-top-line-data-from">positive</a> data from clinical trials with healthy volunteers for its main drug candidate.

Alzheimer's drug developer ProMIS loses over 20% of market capitalization in a day

Fundstrat Global Advisors believes that small-cap stocks could rise 15% in August. The Russell 2000 index finished 1.3% higher on Thursday, July 25, and is now up 11% over the last three months and up 8.5% over the last month. JPMorgan expects returns on small- and mid-cap stocks to be sustainable over a time horizon of 10-15 years.

Small-сap stocks could rise 15% in August – Fundstrat research head

Founded in 1987, Israel’s Gilat Satellite Networks is a veteran in the satellite communication market and is <a href="https://www.mordorintelligence.com/ru/industry-reports/satellite-ground-equipment-market">ranked</a> in the top five globally in satellite ground equipment, according to Mordor Intelligence. Over the years, the company has weathered the financial crisis and the dot-com bubble. Gilat's new goal is to become the leading supplier of in-flight connectivity (IFC) equipment. With in-flight Wi-Fi becoming a differentiating tool for airlines, this market looks promising, which bodes well for Gilat’s stock, suggests investment bank Needham.

How Gilat Satellite aims to become a global IFC market leader

FTAI Aviation, a provider of aftermarket services and jet engine repairs, has helped several small-cap funds tracked by LSEG to outperform the large-cap S&amp;P 500 index this year,  highlights, with the company’s stock among the top 10 holdings of these funds.

Small caps